Lower 12-hour Trough Concentrations of Mycophenolic Acid in Patients with Active Systemic Vasculitides Taking Mycophenolate Mofetil

被引：2

作者：

Djabarouti, Sarah ^{[1
]}

Lazar, Estibaliz ^{[2
]}

Breilh, Dominique ^{[1
]}

Pellegrin, Jean-Luc ^{[2
]}

Viallard, Jean-Francois ^{[2
]}

机构：

[1] Univ Bordeaux Segalen, Lab Pharmacocinet & Pharm Clin, Hop Haut Leveque, CHU Bordeaux,INSERM,U1034, Pessac, France

[2] CHU Bordeaux, Hop Haut Leveque, Serv Med Interne, Pessac, France

来源：

JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷 / 11期

关键词：

DISEASE;

D O I：

10.3899/jrheum.120606

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2223 / 2225

页数：3

共 11 条

[1] Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil
Fructuoso, A. Sanchez
Calvo, N.
Moreno, M. A.
Giorgi, M.
Conesa, J.
Barrientos, A.
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2194 - 2196
[2] Post-dose 12-hour trough concentration of mycophenolate mofetil co-administrated with cyclosporine in dog
Yijyun Li
Zheng Cao
Akiyoshi Hayashi
Keichiro Mie
Maki Ishibashi
畜牧与兽医, 2012, 44(S2) (S2) : 51 - 51
[3] Mycophenolic Acid 12-Hour Area Under the Curve in De Novo Liver Transplant Patients Given Mycophenolate Mofetil at Fixed Versus Concentration-Controlled Doses
Kamar, Nassim
Marquet, Pierre
Gandia, Peggy
Muscari, Fabrice
Lavayssi, Laurence
Esposito, Laure
Guitard, Joelle
Canivet, Cindy
Peron, Jean Marie
Alric, Laurent
Suc, Bertrand
Saint-Marcoux, Franck
Rostaing, Lionel
THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 451 - 456
[4] The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation
Borrows, Richard
Chusney, Gary
Loucaidou, Marina
James, Anthony
Van Tromp, Jen
Cairns, Tom
Griffith, Megan
Hakim, Nadey
McLean, Adam
Palmer, Andrew
Papalois, Vassilios
Taube, David
THERAPEUTIC DRUG MONITORING, 2007, 29 (01) : 122 - 126
[5] Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
Neumann, Irmgard
Fuhrmann, Heinz
Fang, I-Fei
Jaeger, Adelheid
Bayer, Peter
Kovarik, Josef
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (11) : 3514 - 3520
[6] Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels
van Besouw, NM
van der Mast, BJ
Gregoor, PJHS
Hesse, CJ
IJzermans, JNM
van Gelder, T
Weimar, W
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2710 - 2713
[7] Relationship between mycophenolate mofetil side effects and mycophenolic acid plasma trough levels in renal transplant patients
Hübner, GI
Eismann, R
Sziegoleit, W
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2000, 50 (10): : 936 - 940
[8] 12 hour trough mycophenolic acid levels predict rejection, bone marrow suppression, viral infections and diarrhoea in renal transplant recipients immunosuppressed with mycophenolate mofetil and tacrolimus.
Borrows, R
Chusney, G
van Tromp, J
James, A
Stichbury, J
Cairns, T
Griffith, M
Hakim, N
McLean, A
Palmer, A
Papalois, V
Taube, D
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 254 - 254
[9] Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients
Willis, C
Taylor, PJ
Salm, P
Tett, SE
Pillans, PI
THERAPEUTIC DRUG MONITORING, 2000, 22 (05) : 549 - 554
[10] Mycophenolic acid (MPA) AUC(0-12H) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity
Dharancy, Sebastien
Hulin, Anne
Declerck, Nicole
Blanchet, Benoiet
Boleslawski, Emmanuel
Canva, Valerie
Mathurin, Philippe
Pruvot, Francois-Rene
HEPATOLOGY, 2006, 44 (04) : 406A - 407A

← 1 2 →